TD Cowen analyst Charles Rhyee raised the firm’s price target on McKesson (MCK) to $1,000 from $864 and keeps a Buy rating on the shares. The firm said they reported F2Q26 adj. EPS of $9.86 vs cons of $9.03, driven by strength in NA Pharma and benefiting from some 1x items.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MCK: